Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)

NCT02597361 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Ehlers-Danlos Syndrome, Vascular Type

Interventions

DRUG: Irbesartan
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]